Meisner Derek M
Insider CIK 1752461 · GNCA SENIOR VP AND GENERAL COUNSEL · XFOR General Counsel · ABOS Chief Legal Officer & Corp Sec
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals, In | M Exercise deriv | 2026-03-06 | 2026-03-10 | 2,090 | — | $0 | 71,048 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-03-06 | 2026-03-10 | 2,090 | $3.26 | $6.8K | 173,999 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise | 2026-03-06 | 2026-03-10 | 2,090 | $1.85 | $3.9K | 176,089 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise deriv | 2026-02-27 | 2026-03-03 | 9,406 | — | $0 | 73,138 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-02-27 | 2026-03-03 | 9,406 | $3.01 | $28.3K | 173,999 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise | 2026-02-27 | 2026-03-03 | 9,406 | $1.85 | $17.4K | 183,405 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise deriv | 2026-01-28 | 2026-01-28 | 2,671 | — | $0 | 82,544 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-28 | 2026-01-28 | 2,671 | $3.00 | $8.0K | 173,999 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise | 2026-01-28 | 2026-01-28 | 2,671 | $1.85 | $4.9K | 176,670 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise deriv | 2026-01-26 | 2026-01-28 | 15,085 | — | $0 | 85,215 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise | 2026-01-26 | 2026-01-28 | 15,085 | $1.85 | $27.9K | 189,084 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-26 | 2026-01-28 | 15,085 | $3.00 | $45.3K | 173,999 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-23 | 2026-01-23 | 5,633 | $1.90 | $10.7K | 173,999 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-22 | 2026-01-23 | 1,054 | $1.84 | $1.9K | 179,632 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-21 | 2026-01-23 | 2,247 | $1.81 | $4.1K | 180,686 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2026-01-16 | 2026-01-21 | 148,700 | — | $0 | 148,700 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2026-01-16 | 2026-01-21 | 99,133 | — | $0 | 182,933 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-12 | 2026-01-12 | 8,548 | $1.71 | $14.6K | 83,800 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-09 | 2026-01-12 | 5,200 | $1.76 | $9.2K | 92,348 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-08 | 2026-01-12 | 6,819 | $1.82 | $12.4K | 127,640 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-08 | 2026-01-12 | 30,092 | $1.82 | $54.8K | 97,548 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-07 | 2026-01-07 | 1,700 | $1.99 | $3.4K | 144,529 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-07 | 2026-01-07 | 10,070 | $1.99 | $20.0K | 134,459 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-06 | 2026-01-07 | 3,801 | $1.97 | $7.5K | 146,229 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-06 | 2026-01-07 | 7,097 | $1.97 | $14.0K | 150,030 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-05 | 2026-01-07 | 4,000 | $1.96 | $7.8K | 157,127 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2025-01-21 | 2025-01-23 | 3,418 | $1.59 | $5.4K | 161,127 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2025-01-06 | 2025-01-07 | 100,300 | — | $0 | 100,300 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2025-01-06 | 2025-01-07 | 66,800 | — | $0 | 164,545 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2025-01-03 | 2025-01-07 | 11,122 | $1.84 | $20.5K | 97,745 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2024-01-19 | 2024-01-19 | 8,933 | $3.48 | $31.1K | 108,867 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2024-01-02 | 2024-01-04 | 137,000 | — | $0 | 137,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2024-01-02 | 2024-01-04 | 91,000 | — | $0 | 117,800 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2023-01-17 | 2023-01-18 | 120,800 | — | $0 | 120,800 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2023-01-17 | 2023-01-18 | 26,800 | — | $0 | 26,800 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2022-09-06 | 2022-09-07 | 225,000 | — | $0 | 225,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-08-17 | 2022-08-19 | 8,334 | — | $0 | 145,155 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-06-24 | 2022-06-27 | 4,166 | — | $0 | 153,489 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-06-16 | 2022-06-17 | 4,166 | — | $0 | 157,655 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2022-03-01 | 2022-03-01 | 105,000 | — | $0 | 161,821 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-02-11 | 2022-02-14 | 15,909 | — | $0 | 56,821 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2021-08-17 | 2021-08-19 | 8,332 | $5.10 | $42.5K | 72,730 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2021-06-24 | 2021-06-25 | 4,166 | $7.00 | $29.2K | 81,062 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2021-06-23 | 2021-06-25 | 12,500 | — | $0 | 85,228 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2021-06-15 | 2021-06-17 | 4,166 | $7.84 | $32.7K | 72,728 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2021-06-15 | 2021-06-17 | 12,500 | — | $0 | 76,894 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2021-03-24 | 2021-03-25 | 47,728 | — | $0 | 64,394 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2020-09-09 | 2020-09-10 | 8,334 | $8.05 | $67.1K | 16,666 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2020-08-17 | 2020-08-18 | 12,500 | — | $0 | 25,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2020-08-14 | 2020-08-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-11-26 | 2019-11-27 | 55,000 | — | $0 | 55,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2019-02-07 | 2019-02-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2018-09-20 | 2018-09-21 | 200,000 | — | $0 | 200,000 | SEC↗ |